Premature Ejaculation Treatment Global Market 2024 – By Demand, Growth, Trends, Share, Forecast To 2033 | Pfizer Inc., Johnson & Johnson, Merck & Co Inc

The premature ejaculation treatment market size is expected to see strong growth in the next few years. It will grow to $5.62 billion in 2028 at a compound annual growth rate (CAGR) of 9.7%.  The growth in the forecast period can be attributed to continued focus on sexual health, individualized treatment approaches, global efforts to address sexual dysfunction, online health platforms and apps, increased openness in healthcare discussions. Major trends in the forecast period include rise in behavioral and psychosexual therapies, development of novel topical therapies, advancements in pharmacological treatments, integration of telemedicine and online platforms, focus on patient education and counseling, research on novel mechanisms of action..

Order your report now for swift delivery, visit the link:
https://www.thebusinessresearchcompany.com/report/premature-ejaculation-treatment-global-market-report

Segmentation & Regional Insights
The premature ejaculation treatment market covered in this report is segmented –
1) By Type: Antidepressants (SSRIs), Phosphodiesterase-5 Inhibitors, Topical Anesthetics, Analgesics, Other Treatment
2) By Route of Administration: Oral, Topical
3) By Distribution Channel: Retail, Direct-To-Consumer
4) By Application: Hospital, Retail Pharmacy, Online Pharmacy, Other Applications

North America was the largest region in the premature rjaculation treatment market in 2023, and is expected to be the fastest-growing region in the forecast period. The regions covered in the premature ejaculation treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Intrigued to explore the contents? Secure your hands-on a free sample copy of the report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=13518&type=smp

Major Driver Impacting Market Growth
The increasing prevalence of sexual disorders is expected to propel the growth of the premature ejaculation treatment market going forward. Sexual disorder or dysfunction refers to the difficulty faced by both men and women during any phase of regular intimate activity. Premature ejaculation is a sexual disorder where premature ejaculation treatment involving medications or therapeutic approaches addresses and controls this condition. For instance, in November 2021, according to a survey of 2,000 UK adults conducted by Pharmacy Direct GB, a UK-based online pharmacy, around 48% of UK residents reported experiencing erectile dysfunction, representing about 16.5 million individuals. The National Health Service spent over $17,9 million (£13 million) for Erectile Dysfunction treatment prescriptions in 2021. Further, in July 2022, according to a survey of 1,000 men across the UK by Click2Pharmacy, a UK-based provider of local prescription treatment services, around 58.2% experienced erectile dysfunction in the UK and 3 in 4 men between the ages of 25 and 34 experience erectile dysfunction in 2022. Therefore, the increasing prevalence of sexual disorders is driving the growth of the premature ejaculation treatment market.

Key Industry Players
Major companies operating in the premature ejaculation treatment market report are Pfizer Inc., Johnson & Johnson, Merck & Co Inc., AbbVie Inc., Bayer AG, Novartis AG, AstraZeneca PLC, GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Teva Pharmaceutical Industries Ltd., Sandoz International GmbH, Sun Pharmaceutical Industries Ltd., Menarini Group, Lupin Limited., Amneal Pharmaceuticals Inc., Mankind Pharma Ltd., Cipla Limited, Alembic Pharmaceuticals Limited, Torrent Pharmaceuticals Ltd., ANI Pharmaceuticals Inc., Sagent Pharmaceuticals Inc., Vivus Inc., Absorption Pharmaceuticals LLC, Innovus Pharmaceuticals Inc., Sunrise Pharmaceuticals Inc., Solco Healthcare US LLC, Apricus Biosciences Inc., Regent Pacific Group Limited, Endurance RP Ltd.</b

The premature ejaculation treatment market report table of contents includes:
1. Executive Summary
2. Premature Ejaculation Treatment Market Characteristics
3. Premature Ejaculation Treatment Market Trends And Strategies
4. Premature Ejaculation Treatment Market – Macro Economic Scenario
5. Global Premature Ejaculation Treatment Market Size and Growth
……………………………………
32. Global Premature Ejaculation Treatment Market Competitive Benchmarking
33. Global Premature Ejaculation Treatment Market Competitive Dashboard
34. Key Mergers And Acquisitions In The Premature Ejaculation Treatment Market
35. Premature Ejaculation Treatment Market Future Outlook and Potential Analysis
36. Appendix

Explore the trending research reports from TBRC:
https://goodprnews.com/software-defined-storage-global-market-size/
https://goodprnews.com/tcr-therapy-global-market-size/
https://goodprnews.com/water-hardness-test-strip-global-market-size/
https://topprnews.com/software-defined-storage-global-market-share/
https://topprnews.com/tcr-therapy-global-market-share/
https://topprnews.com/water-hardness-test-strip-global-market-share/

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model